Results 81 to 90 of about 3,318,202 (320)

POTASSIUM PERMANGANATE AS A CURATIVE AGENT IN DERMATOLOGIC DISEASES [PDF]

, 1922
Samuel M. Feldman
openalex   +1 more source

Pharmacodynamic Effects of Litifilimab in Lupus in the LILAC Phase II Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines

Arthritis &Rheumatology, Accepted Article.
Objective The pharmacodynamic effects of litifilimab on type I interferon (IFN) response and correlations with clinical outcomes were investigated in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Methods Participants from Part A (SLE) or Part B (CLE with/without SLE) of the randomized phase II LILAC trial who received ...
Richard Furie, Victoria P. Werth, Eric Milliman, Kyle Ferber, Roland Brown, Jad Zoghbi, Nathalie Franchimont, Youmna Lahoud, Catherine Barbey   +8 more
wiley   +1 more source

Sulfonamide Allergies

Pharmacy, 2019
As one of the earliest developed antimicrobial classes, sulfonamides remain important therapeutic options for the empiric and definitive treatment of various infectious diseases.
Amber Giles, Jaime Foushee, Evan Lantz, Giuseppe Gumina   +3 more
doaj   +1 more source

SARS‐CoV‐2 (COVID‐19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group

, 2021
Charlie Wang, Marius Rademaker, Bruce Tate, Christopher M. Baker, Peter Foley   +4 more
openalex   +1 more source

B cells and systemic sclerosis interstitial lung disease

Arthritis &Rheumatology, Accepted Article.
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman, Voon Ong, Christopher Denton   +2 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Dermatological pharmacology: systemic agents

Medicine, 2004
Abstract Systemic therapy is indicated for the treatment of skin disorders when the extent or severity of the disease would make topical therapy impractical or insufficiently effective, or because the drug used is not active when topically administered.
openaire   +2 more sources

Paclitaxel-related dermatological problems: Not only alopecia occurs

Taiwanese Journal of Obstetrics & Gynecology, 2019
Objective: Dermatological problems after chemotherapy are often neglected with gynecological oncologists. Since paclitaxel is one of most popular agents for gynecology organ-related cancers, dermatologic change after paclitaxel treatment is seldom ...
Ming-Hsuan Su, Guan-Yeu Chen, Jun-Hung Lin, Howard Hao Lee, Kai-Cheng Chung, Peng-Hui Wang   +5 more
doaj  

Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders

Biomolecules
Neutrophil-mediated inflammation is a key feature of immune-mediated chronic skin disorders, but the mechanistic understanding of neutrophil involvement in these conditions remains incomplete.
Ludovica Franceschin, Alessia Guidotti, Roberto Mazzetto, Jacopo Tartaglia, Christian Ciolfi, Mauro Alaibac, Alvise Sernicola   +6 more
doaj   +1 more source

Fármacos de uso frecuente en dermatología como terapia para COVID-19

Actas Dermo-Sifiliográficas, 2021
Resumen: Frente a la necesidad de encontrar una alternativa terapéutica que logre disminuir el impacto negativo de la COVID-19 y mejore el pronóstico actual de los pacientes, investigadores de todo el mundo se esfuerzan por aportar información que nos ...
M. Ortega-Peña, R. González-Cuevas
doaj